Healthcare
Creative Biolabs Advances Microbiome-Based Drug Development with Enhanced LBP Analytics
Creative Biolabs has introduced an advanced microbial service platform to streamline the development of microbiome-based drugs, addressing key challenges in strain characterization, contaminant detection, and formulation stability.
Award-Winning Documentary 'Where the Horses Heal the Soul' to Screen in Austin, Supporting Equine Assisted Services
The documentary highlights the transformative power of equine assisted services for individuals facing physical and emotional challenges, showcasing stories of veterans, a teenager with Down syndrome, and a young woman with cerebral palsy.
VERAXA Biotech AG and Voyager Acquisition Corp. Announce $1.64 Billion Merger to Advance Cancer Therapies
VERAXA Biotech AG and Voyager Acquisition Corp. have agreed to a $1.64 billion merger, aiming to accelerate the development of innovative cancer therapies through VERAXA's Bi-Targeted Antibody Cytotoxicity platform.
Calidi Biotherapeutics Appoints Biotech Veteran Eric Poma as CEO to Drive Growth
Calidi Biotherapeutics Inc. has named Eric Poma, PhD, as its new CEO and board member, marking a strategic step to advance its innovative cancer therapies towards commercialization.
Pacylex Pharmaceuticals Showcases Promising NMT Inhibitors at BIO Annual Meeting
Pacylex Pharmaceuticals Inc. highlights its innovative N-myristoyltransferase inhibitors (NMTis) at the BIO International Convention, showcasing potential breakthroughs in cancer treatment through oral zelenirstat and ADC payloads.
Glucotrack Innovates Diabetes Management with Implantable Glucose Monitor
Glucotrack Inc. is revolutionizing diabetes care with its fully implantable continuous blood glucose monitoring system, addressing key patient concerns and setting new standards for accuracy and convenience.
GeoVax to Showcase Positive Immune Response Data for GEO-CM04S1 in CLL Patients at EHA 2025 Congress
GeoVax Labs, Inc. will present clinical data at the European Hematology Association 2025 Congress, demonstrating the superior cellular immune response of its GEO-CM04S1 vaccine in chronic lymphocytic leukemia patients compared to mRNA-based vaccines.
Tonix Pharmaceuticals to Showcase Innovations at 2025 BIO International Convention
Tonix Pharmaceuticals Holding Corp. is set to present at the 2025 BIO International Convention, highlighting its advancements in pain management and public health solutions, including a potential new treatment for fibromyalgia.
HPS and PayMedix Partner with Gravie to Enhance Healthcare Access and Payment Simplicity
A strategic partnership between HPS, PayMedix, and Gravie aims to improve healthcare access and simplify payments for small and midsize businesses in Wisconsin, offering a comprehensive provider network and a transparent payment platform.
Rising Breast Cancer Cases Among Younger Women Highlight Need for Advanced Treatments
Recent announcements by young celebrities about their breast cancer diagnoses underscore a worrying trend of increasing prevalence among women under 50, prompting calls for more effective treatments and research into the causes.
Medicus Pharma Ltd. (NASDAQ: MDCX) Strategically Positions Itself in the Rapidly Growing $5 Trillion Biotech Market
Medicus Pharma Ltd. is leveraging the aging global population and technological advancements in biopharma to address chronic diseases, positioning itself for significant growth in the $5 trillion biotech market by 2034.
ONAR Holding Corp. Strengthens Board with Appointment of Howard Palefsky
ONAR Holding Corp. (OTCQB: ONAR) enhances its governance and strategic direction by appointing Howard Palefsky, a seasoned life sciences executive, to its Board of Directors and as Chair of the Governance and Nominating Committee, signaling a strong move towards growth in the healthcare marketing sector.
Oragenics Inc. to Showcase Concussion Treatment Candidate at Major 2025 Biotech and Neurotrauma Events
Oragenics Inc. (NYSE American: OGEN) is set to present its intranasal neurosteroid candidate for concussion treatment, ONP-002, at two significant 2025 events, highlighting its potential impact on neurology and pharmaceutical sectors.
Tevard Biosciences Appoints Dr. Elisabeth Gardiner as Chief Scientific Officer to Advance tRNA-Based Therapies
Tevard Biosciences has appointed Dr. Elisabeth Gardiner as its new Chief Scientific Officer, marking a significant step in advancing its tRNA-based therapies for genetic diseases, with implications for treating conditions like Duchenne Muscular Dystrophy and TTN-related dilated cardiomyopathy.
Ingrained Recovery Expands Equine Therapy Program Accessibility in Georgia
Ingrained Recovery enhances its Equine Therapy program by accepting a broader range of insurance plans, including GEHA, TRICARE, and GHI, making holistic treatment more accessible to individuals and families dealing with substance use, trauma, and mental health conditions.
Alfa Cytology Launches PARP Inhibitors Development Services for Advanced Cancer Treatment
Alfa Cytology has introduced comprehensive development services for PARP inhibitors, offering a promising avenue for more precise and personalized cancer treatments, particularly for cancers with genetic mutations like BRCA1 and BRCA2.
NFL Alumni and American Heart Association Team Up to Promote Heart Health During Men's Health Week
The American Heart Association and NFL Alumni are collaborating to highlight Life’s Essential 8™, key components to prevent heart disease and stroke, during Men’s Health Week, aiming to inspire men to take proactive steps towards better heart health.
The Maercks Institute Revolutionizes Facial Rejuvenation with Awake Deep Plane Facelift
The Maercks Institute's latest video showcases a young professional undergoing a deep plane facelift without anesthesia, marking a significant shift in the approach to facial rejuvenation for younger demographics.
Aditxt Inc. Strengthens Board with Appointment of Evofem CEO Saundra Pelletier
Aditxt Inc. (NASDAQ: ADTX) has appointed Saundra Pelletier, CEO of Evofem Biosciences, to its Board of Directors, signaling a strategic focus on women's health and commercialization efforts.
FDA's Rapid AI Integration Highlights Urgency in Modernizing Regulatory Processes
The U.S. Food and Drug Administration's deployment of the Elsa AI tool marks a significant step towards modernizing regulatory reviews, with Lantern Pharma CEO Panna Sharma noting the aggressive timeline reflects the agency's urgency.
American Heart Association Certifies First Comprehensive Chest Pain Centers in India and Mexico
The American Heart Association has certified the first Comprehensive Chest Pain Centers in India and Mexico, marking a significant advancement in global cardiac care and addressing the leading cause of death worldwide.
Nutriband Inc. Secures U.S. Patent for Innovative Abuse-Deterrent Transdermal Technology
Nutriband Inc. has been granted a U.S. patent for its Aversa(TM) technology, marking a significant step forward in the fight against drug abuse and misuse with its abuse-deterrent transdermal products.
Clene Inc. CEO to Present at Investor Summit Virtual, Highlighting Progress in Neurodegenerative Disease Treatment
Clene Inc.'s CEO Rob Etherington will update investors on the company's advancements in treating neurodegenerative diseases at the Investor Summit Virtual, showcasing potential breakthroughs in mitochondrial health and neuronal protection.
GeoVax's Multi-Antigen COVID-19 Vaccine Shows Promise Against Variants
GeoVax Labs, Inc. reports preclinical success of its multi-antigen COVID-19 vaccines, GEO-CM04S1 and GEO-CM02, in providing durable, cross-reactive immunity against SARS-CoV-2 variants, including Omicron XBB.1.5, highlighting the potential for broader protection without the need for frequent updates.
LEKSUM and SLU Partner to Pioneer Muscle Research in Unique ICU Lab
LEKSUM LLC's collaboration with SLU establishes a groundbreaking muscle research lab, led by Dr. Lars Larsson, to study long-term ICU conditions and develop therapies for muscle myopathies affecting millions annually.
Skin, Bones, Hearts & Private Parts to Host Pensacola CME Conference
The upcoming CME conference in Pensacola Beach, FL, offers healthcare professionals the opportunity to earn up to 39 CME credits across a variety of specialties, emphasizing practical knowledge for immediate application in patient care.
Urgent Call for Parliamentary Intervention to Redirect CERN Funding Towards Life-Saving Innovations
The Crosetto Foundation highlights decades of misallocated funding at CERN, advocating for the adoption of Dario Crosetto's 3D-Flow technology to save billions in taxpayer money and accelerate advancements in cancer detection and particle physics.
Icarus Expands Mental Health Services in Las Vegas with Accredited Treatment Program
Icarus has launched an accredited mental health treatment program in Las Vegas, offering comprehensive care for a range of disorders and a specialized gambling rehab program, marking a significant step in accessible mental health and addiction care in the Southwest.
Sandoval Law Firm Expands Efforts to Aid Texas Families Affected by Preventable Birth Injuries
The Sandoval Law Firm is intensifying its efforts to support Texas families impacted by preventable birth injuries, highlighting the significant number of such cases annually and the financial and emotional toll on affected families.
Quarterfield Dental Arts Embraces New Leadership with Dr. Pooja Soni
Dr. Pooja Soni takes over Quarterfield Dental Arts in Glen Burnie, promising to uphold the practice's legacy while introducing advanced dental care and a patient-first approach.